Genmab is getting into a brand new part in its growth that can require further focus and time from CEO Jan Van de Winkel, who has due to this fact stepped down from Leo Pharma’s Board of Administrators.
发布者:BY ULRICH QUISTGAARD,转转请注明出处:https://robotalks.cn/genmab-ceo-too-busy-for-leo-pharma-board-as-own-firm-enters-next-phase/